Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.
about
Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Co-targeting the tumor endothe ...... emarkable therapeutic outcome.
@en
Co-targeting the tumor endothe ...... emarkable therapeutic outcome.
@nl
type
label
Co-targeting the tumor endothe ...... emarkable therapeutic outcome.
@en
Co-targeting the tumor endothe ...... emarkable therapeutic outcome.
@nl
prefLabel
Co-targeting the tumor endothe ...... emarkable therapeutic outcome.
@en
Co-targeting the tumor endothe ...... emarkable therapeutic outcome.
@nl
P2093
P2860
P50
P356
P1433
P1476
Co-targeting the tumor endothe ...... emarkable therapeutic outcome.
@en
P2093
Adva Krivitsky
Ana Sousa-Herves
Anat Eldar-Boock
Eilam Yeini
Jack Henkin
Laura Isabel Vossen
Noam Auslander
Rachel Grossman
Rainer Haag
P2860
P356
10.7554/ELIFE.25281
P407
P50
P577
2017-10-04T00:00:00Z